can you lose weight on 2.5 mg tirzepatide regain after the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity Mounjaro Tirzepatide Weight Loss Injection

Clinical trial results have shown that Retatrutide, an experimental obesity drug emerging as a competitor to the blockbuster treatments Wegovy and Zepbound, not only reduces weight but is also effective in treating fatty liver, a condition where fat accumulates in the liver

Research shows that absorption rates are similar across approved sites (abdomen, thigh, upper arm), but the injection site can affect comfort and consistency

For some people, this shift is one of the most meaningful changes they notice

Looking beyond Wegovy and Zepbound, there are several other drugs in development that provide even greater weight reduction and may have fewer side effects than the currently approved medicines

The OFA argued that the FDAs removal of tirzepatide, the active ingredient in these drugs, from its shortage list would limit patient access to crucial treatments and drive up drug costs